ghk-cu reconstitution 50mg Vial | Copper Peptide GHK-Cu 50mg Vial | High-Purity

Springer, Berlin, Heidelberg

Streeper 1997)

Injectable healing protocol: 23 mg daily (upper end of range), systemic injection - not into the wound itself - daily until the wound resolves, plus 12 weeks maintenance Topical healing protocol: 2 %4 % in a wound-appropriate vehicle applied 23 times daily to wound margins (never into an open, actively bleeding wound) under clinician supervision Stacking: GHK-Cu pairs exceptionally well with BPC-157 and TB-500 - the so-called GLOW stack - for complex healing cases

Side effects at the 12 mg level roughly doubled

At room temperature, the rate of oxidation in lyophilized form is approximately 4060 times slower than in reconstituted solution

These early safety and pharmacokinetic studies preceded Phase 2 dose-ranging work in 20042006 and the Phase 3 pivotal trials that began in 2006